E

EstechPharma Co Ltd
KOSDAQ:041910

Watchlist Manager
EstechPharma Co Ltd
KOSDAQ:041910
Watchlist
Price: 6 220 KRW 1.3% Market Closed
Market Cap: 84B KRW

Wall Street
Price Targets

Price Targets Summary
EstechPharma Co Ltd

There are no price targets for EstechPharma Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
EstechPharma Co Ltd Competitors:
Price Targets
2005
SSY Group Ltd
40% Upside
TARS
Tarsus Pharmaceuticals Inc
8% Upside
688176
Jiangsu Yahong Meditech Co Ltd
15% Downside
SANOFI
Sanofi India Ltd
24% Upside
300723
Yipinhong Pharmaceutical Co Ltd
32% Upside
000513
Livzon Pharmaceutical Group Inc
29% Upside
185750
Chong Kun Dang Pharmaceutical Corp
38% Upside

Revenue
Forecast

Revenue Estimate
EstechPharma Co Ltd

For the last 13 years the compound annual growth rate for EstechPharma Co Ltd's revenue is 0%. The projected CAGR for the next 13 years is 0%.

0%
Past Growth
0%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
EstechPharma Co Ltd

Operating Income forecast
is not available for
EstechPharma Co Ltd

Net Income
Forecast

Net Income Estimate
EstechPharma Co Ltd

For the last 13 years the compound annual growth rate for EstechPharma Co Ltd's net income is -6%. The projected CAGR for the next 13 years is 8%.

-6%
Past Growth
8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EstechPharma Co Ltd's stock price target?
Not Available

EstechPharma Co Ltd doesn't have any price targets made by Wall Street professionals.

What is EstechPharma Co Ltd's Revenue forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for EstechPharma Co Ltd's revenue is 0%. The projected CAGR for the next 13 years is 0%.

What is EstechPharma Co Ltd's Net Income forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for EstechPharma Co Ltd's net income is -6%. The projected CAGR for the next 13 years is 8%.

Back to Top